Noncoding RNA Roles in Pharmacogenomic Responses to Aspirin: New Molecular Mechanisms for an Old Drug

被引：3

作者：

Khazeei Tabari, Mohammad Amin ^{[1
,2
]}

Mishan, Mohammad Amir ^{[3
]}

Moradi, Mona ^{[4
]}

Khandan, Mohanna ^{[1
,2
]}

Khoshhal, Hooman ^{[1
,2
]}

Mahrooz, Abdolkarim ^{[4
]}

Bagheri, Abouzar ^{[4
,5
]}

机构：

[1] Mazandaran Univ Med Sci, Student Res Comm, Sari, Iran

[2] Mazandaran Univ Med Sci, USERN Off, Sari, Iran

[3] Shahid Beheshti Univ Med Sci, Res Inst Ophthalmol & Vis Sci, Ocular Tissue Engn Res Ctr, Tehran, Iran

[4] Mazandaran Univ Med Sci, Fac Med, Mol & Cell Biol Res Ctr, Dept Clin Biochem & Med Genet, Sari, Iran

[5] Mazandaran Univ Med Sci, Fac Med, Gastrointestinal Canc Res Ctr, Dept Clin Biochem & Med Genet, Sari, Iran

来源：

BIOMED RESEARCH INTERNATIONAL | 2021年 / 2021卷

关键词：

TRIGGERED RESOLVIN D1; HEPATIC ISCHEMIA/REPERFUSION INJURY; CANCER PREVENTION; D-SERIES; MICRORNAS; INFLAMMATION; CELLS; MIR-21; ALPHA; RESISTANCE;

D O I：

10.1155/2021/6830560

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aspirin, as one of the most frequently prescribed drugs, can have therapeutic effects on different conditions such as cardiovascular and metabolic disorders and malignancies. The effects of this common cardiovascular drug are exerted through different molecular and cellular pathways. Altered noncoding RNA (ncRNA) expression profiles during aspirin treatments indicate a close relationship between these regulatory molecules and aspirin effects through regulating gene expressions. A better understanding of the molecular networks contributing to aspirin efficacy would help optimize efficient therapies for this very popular drug. This review is aimed at discussing and highlighting the identified interactions between aspirin and ncRNAs and their targeting pathways and better understanding pharmacogenetic responses to aspirin.

引用

页数：14

共 50 条

[1] The roles and mechanisms of coding and noncoding RNA variations in cancer
Kim, Sang Yean
Na, Min Jeong
Yoon, Sungpil
Shin, Eunbi
Ha, Jin Woong
Jeon, Soyoung
Nam, Suk Woo
EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (09): : 1909 - 1920
[2] Aspirin: New life for an old drug
Martin, C
CHEMISTRY IN BRITAIN, 1996, 32 (06) : 8 - 10
[3] ASPIRIN - NEW INDICATIONS FOR AN OLD DRUG
CHASTAIN, CB
COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 1987, 9 (02): : 165 - &
[4] The impact of noncoding RNA on the biochemical and molecular mechanisms of aging
Bates, David J.
Liang, Ruqiang
Li, Na
Wang, Eugenia
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (10): : 970 - 979
[5] Molecular Mechanisms and Function Prediction of Long Noncoding RNA
Ma, Handong
Hao, Yun
Dong, Xinran
Gong, Qingtian
Chen, Jingqi
Zhang, Jifeng
Tian, Weidong
SCIENTIFIC WORLD JOURNAL, 2012,
[6] Complex roles of the old drug aspirin in cancer chemoprevention and therapy
Hua, Hui
Zhang, Hongying
Kong, Qingbin
Wang, Jiao
Jiang, Yangfu
MEDICINAL RESEARCH REVIEWS, 2019, 39 (01) : 114 - 145
[7] Aspirin: Old drug, new uses and challenges
Yeomans, Neville D.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (03) : 426 - 431
[8] Exploring the roles and molecular mechanisms of RNA binding proteins in the sorting of noncoding RNAs into exosomes during tumor progression
Wang, Ting
Zhang, Hui
JOURNAL OF ADVANCED RESEARCH, 2024, 65 : 105 - 123
[9] Long Noncoding RNA UCA1 in Gastrointestinal Cancers: Molecular Regulatory Roles and Patterns, Mechanisms, and Interactions
Ramli, Suaidah
Sim, Maw Shin
Guad, Rhanye M.
Gopinath, Subash C. B.
Subramaniyan, Vetriselvan
Fuloria, Shivkanya
Fuloria, Neeraj K.
Choy, Ker Woon
Rana, Sohel
Wu, Yuan Seng
JOURNAL OF ONCOLOGY, 2021, 2021
[10] Molecular mechanisms of parthenolide's action: Old drug with a new face
Koprowska, Kamila
Czyz, Malgorzata
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2010, 64 : 100 - 114

← 1 2 3 4 5 →